Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 11 -20 of 97 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


11.		Phase III Adjuvant Immunotherapy with C. parvum and Levamisole and Radiotherapy for Inoperable Lung Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				no age specified								SEG-76LUN308 SEG-76LUN0203

Last Modified: 7/1/1997


12.		Phase III Radiotherapy with or without ADR Chemotherapy and/or Levamisole Immunotherapy for Limited Squamous Lung Carcinoma (Summary Last Modified 07/97)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				no age specified				NCI				SWOG-7635

Last Modified: 7/9/2007


13.		Phase III Induction with VMCP plus VCAP or VBAP vs L-PAM/PRED and Maintenance with VMCP with or without Levamisole for Myeloma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				no age specified				NCI				SWOG-7704/7705 MDAR-204


14.		Phase III Adjuvant Immunotherapy and Radiotherapy for Resectable Squamous, Adeno or Large Cell Lung Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				no age specified				NCI				SWOG-7718

Last Modified: 7/1/1997


15.		Phase III Induction with VCR/5-FU/MTX/CTX/PRED plus Maintenance with CMPF vs CMPF plus LEV Immunotherapy for ER-Breast Cancer (Summary Last Modified 07/97)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				no age specified				NCI				SWOG-7725

Last Modified: 7/1/1997


16.		Phase III Chemotherapy with BHD (BCNU/HU/DTIC) and Levamisole Immunotherapy vs DTIC/ACT-D for Disseminated Melanoma (Summary Last Modified 07/97)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				no age specified				NCI				SWOG-7727/28


17.		Phase III Chemotherapy with Various Combinations of VCR, L-PAM, CTX, BCNU, ADR, PRED, and LEV for Multiple Myeloma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				no age specified				NCI				SWOG-7927/28 MDAR-377, SWOG-7928


18.		Surgery and Adjuvant Immunotherapy with BCG and Levamisole for Completely Resected non-Small Cell Cancer of the Lung

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				no age specified								WA-LUN-1 NOG-2177

Last Modified: 7/20/2007


19.		Phase III Adjuvant Immunotherapy with Levamisole with Concurrent Radiotherapy for Unresectable non-Small Cell Lung Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				no age specified				NCI				RTOG-7811


20.		Phase III Postoperative Radiotherapy with/without Levamisole Immunotherapy for non-Oat Cell Lung Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				18 to 75				NCI				RTOG-7927

Select All on One Page


					< Previous 1 2 3 4 5 Next >

| | | | | | | |

A Service of the National Cancer Institute